4:42 PM
 | 
Dec 28, 2012
 |  BC Extra  |  Top Story

FDA approves Eliquis

FDA approved Eliquis apixaban from Bristol-Myers Squibb Co. (NYSE:BMY) and Pfizer Inc. (NYSE:PFE) to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation (AF). The direct Factor Xa inhibitor had a March 17, 2013,...

Read the full 193 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >